ChemImpex Ciprofibrate; 98% (Assay by titration, GC); 52214-84-3; MFCD00467135, 5G

Ciprofibrate is a potent lipid-regulating agent primarily used in the management of dyslipidemia, particularly for lowering triglyceride levels and increasing high-density lipoprotein (HDL) cholesterol. This compound is recognized for its unique mechanism of action, which involves the activation of peroxisome proliferator-activated receptors (PPARs), leading to enhanced fatty acid oxidation and improved lipid profiles. Its efficacy in clinical settings has made it a valuable asset in the treatment of metabolic syndrome and cardiovascular diseases.

In addition to its therapeutic applications, Ciprofibrate has been utilized in various research settings to explore its effects on lipid metabolism and potential benefits in preventing atherosclerosis. Researchers appreciate its favorable safety profile and the ability to combine it with other lipid-lowering therapies, making it a versatile option for comprehensive lipid management. With its proven benefits and ongoing research into its broader applications, Ciprofibrate stands out as a significant compound for both clinical and research purposes.

Specifications

Safety & Regulations